Uninterrupted patient access as devices can remain on the GB market without additional checks Long-term regulatory certainty for manufacturers, enabling better planning and investment decisions | Reduced regulatory burden and cost: no duplicate regulatory and administrative processes for undergoing UKCA re-certification Supports innovation and competitiveness in the UK MedTech sector |
